schliessen

Filtern

 

Bibliotheken

B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?

Cardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE) especially during the late phase of the disease. This study was conducted to evaluate B-type natriuretic peptide (BNP) levels in female SLE patients without cardiac symptoms and to investigate whethe... Full description

Journal Title: Clinical Rheumatology 2007, Vol.26(10), pp.1701-1704
Main Author: Karadag, Omer
Other Authors: Calguneri, Meral , Yavuz, Bunyamin , Atalar, Enver , Akdogan, Ali , Kalyoncu, Umut , Kiraz, Sedat , Aksoyek, Serdar , Ozmen, Ferhan , Ertenli, A.
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0770-3198 ; E-ISSN: 1434-9949 ; DOI: 10.1007/s10067-007-0575-4
Link: http://dx.doi.org/10.1007/s10067-007-0575-4
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: springer_jour10.1007/s10067-007-0575-4
title: B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
format: Article
creator:
  • Karadag, Omer
  • Calguneri, Meral
  • Yavuz, Bunyamin
  • Atalar, Enver
  • Akdogan, Ali
  • Kalyoncu, Umut
  • Kiraz, Sedat
  • Aksoyek, Serdar
  • Ozmen, Ferhan
  • Ertenli, A.
subjects:
  • B-type natriuretic peptide (BNP)
  • Cardiovascular diseases
  • Diastolic dysfunction
  • Novel cardiovascular risk factors
  • Systemic lupus erythematosus (SLE)
ispartof: Clinical Rheumatology, 2007, Vol.26(10), pp.1701-1704
description: Cardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE) especially during the late phase of the disease. This study was conducted to evaluate B-type natriuretic peptide (BNP) levels in female SLE patients without cardiac symptoms and to investigate whether BNP levels correlated with echocardiographic findings. We studied 59 women with SLE and 33 healthy women. SLE patients with history of cardiac disease, diabetes mellitus, hypertension, and other inflammatory diseases were excluded from the study. All subjects had a complete history and physical examination. Overall disease activity assessment in SLE patients at the time of the study were derived by calculation of SLE disease activity index (SLEDAI). BNP levels were determined, and transthoracic echocardiography were performed in all subjects. There was no difference between SLE patients and controls in terms of age, blood pressure, smoking status, plasma glucose, creatinine levels, and lipid profiles. Nine patients had SLEDAI score greater than 5. All subjects had an EF greater than 55%. Diastolic dysfunction was more frequent in lupus patients than in controls (15 [25.4%] vs. 2 [6%]; p  = 0.022). BNP levels of SLE patients were significantly higher than controls (median 17.9 range [5–211] pg/ml vs. median 14.7 range [5–39.7] pg/ml; p  = 0.033). Twenty-seven of the SLE patients (46%) and seven of the controls (21%) had BNP levels greater than or equal to 20 pg/ml ( p  = 0.019). There were no differences in BNP levels of SLE patients with and without diastolic dysfunction (median 17.8 range [5–117] pg/ml vs. median 18.5 range [5–211] pg/mL; p  = NS). BNP levels were positively correlated with left atrium diameter ( r 2  = 0.39, p  = 0.001). BNP levels did not correlate with erythrocyte sedimentation rate/C-reactive protein levels, SLEDAI scores, total steroid dosage used, or other echocardigraphic parameters. BNP levels were increased in female SLE patients without cardiac symptoms as compared to healthy controls. Although none of the SLE patients in our study had clinical signs of ischemic heart disease, increased levels of BNP in SLE patients might be a reflection of a ischemic myocardial tissue.
language: eng
source:
identifier: ISSN: 0770-3198 ; E-ISSN: 1434-9949 ; DOI: 10.1007/s10067-007-0575-4
fulltext: fulltext
issn:
  • 1434-9949
  • 14349949
  • 0770-3198
  • 07703198
url: Link


@attributes
ID675808872
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1007/s10067-007-0575-4
sourceidspringer_jour
recordidTN_springer_jour10.1007/s10067-007-0575-4
sourcesystemPC
pqid68272067
galeid168691743
display
typearticle
titleB-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
creatorKaradag, Omer ; Calguneri, Meral ; Yavuz, Bunyamin ; Atalar, Enver ; Akdogan, Ali ; Kalyoncu, Umut ; Kiraz, Sedat ; Aksoyek, Serdar ; Ozmen, Ferhan ; Ertenli, A.
ispartofClinical Rheumatology, 2007, Vol.26(10), pp.1701-1704
identifier
subjectB-type natriuretic peptide (BNP) ; Cardiovascular diseases ; Diastolic dysfunction ; Novel cardiovascular risk factors ; Systemic lupus erythematosus (SLE)
descriptionCardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE) especially during the late phase of the disease. This study was conducted to evaluate B-type natriuretic peptide (BNP) levels in female SLE patients without cardiac symptoms and to investigate whether BNP levels correlated with echocardiographic findings. We studied 59 women with SLE and 33 healthy women. SLE patients with history of cardiac disease, diabetes mellitus, hypertension, and other inflammatory diseases were excluded from the study. All subjects had a complete history and physical examination. Overall disease activity assessment in SLE patients at the time of the study were derived by calculation of SLE disease activity index (SLEDAI). BNP levels were determined, and transthoracic echocardiography were performed in all subjects. There was no difference between SLE patients and controls in terms of age, blood pressure, smoking status, plasma glucose, creatinine levels, and lipid profiles. Nine patients had SLEDAI score greater than 5. All subjects had an EF greater than 55%. Diastolic dysfunction was more frequent in lupus patients than in controls (15 [25.4%] vs. 2 [6%]; p  = 0.022). BNP levels of SLE patients were significantly higher than controls (median 17.9 range [5–211] pg/ml vs. median 14.7 range [5–39.7] pg/ml; p  = 0.033). Twenty-seven of the SLE patients (46%) and seven of the controls (21%) had BNP levels greater than or equal to 20 pg/ml ( p  = 0.019). There were no differences in BNP levels of SLE patients with and without diastolic dysfunction (median 17.8 range [5–117] pg/ml vs. median 18.5 range [5–211] pg/mL; p  = NS). BNP levels were positively correlated with left atrium diameter ( r 2  = 0.39, p  = 0.001). BNP levels did not correlate with erythrocyte sedimentation rate/C-reactive protein levels, SLEDAI scores, total steroid dosage used, or other echocardigraphic parameters. BNP levels were increased in female SLE patients without cardiac symptoms as compared to healthy controls. Although none of the SLE patients in our study had clinical signs of ischemic heart disease, increased levels of BNP in SLE patients might be a reflection of a ischemic myocardial tissue.
languageeng
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1007/s10067-007-0575-4$$EView_full_text_in_Springer_(Subscribers_only)
search
creatorcontrib
0Karadag, Omer, Ihsan
1Calguneri, Meral, Ihsan
2Yavuz, Bunyamin, Ihsan
3Atalar, Enver, Ihsan
4Akdogan, Ali, Ihsan
5Kalyoncu, Umut, Ihsan
6Kiraz, Sedat, Ihsan
7Aksoyek, Serdar, Ihsan
8Ozmen, Ferhan, Ihsan
9Ertenli, A., Ihsan
titleB-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
descriptionCardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE) especially during the late phase of the disease. This study was conducted to evaluate B-type natriuretic peptide (BNP) levels in female SLE patients without cardiac symptoms and to investigate whether BNP levels correlated with echocardiographic findings. We studied 59 women with SLE and 33 healthy women. SLE patients with history of cardiac disease, diabetes mellitus, hypertension, and other inflammatory diseases were excluded from the study. All subjects had a complete history and physical examination. Overall disease activity assessment in SLE patients at the time of the study were derived by calculation of SLE disease activity index (SLEDAI). BNP levels were determined, and transthoracic echocardiography were performed in all subjects. There was no difference between SLE patients and controls in terms of age, blood pressure, smoking status, plasma glucose, creatinine levels, and lipid profiles. Nine patients had SLEDAI score greater than 5. All subjects had an EF greater than 55%. Diastolic dysfunction was more frequent in lupus patients than in controls (15 [25.4%] vs. 2 [6%]; p  = 0.022). BNP levels of SLE patients were significantly higher than controls (median 17.9 range [5–211] pg/ml vs. median 14.7 range [5–39.7] pg/ml; p  = 0.033). Twenty-seven of the SLE patients (46%) and seven of the controls (21%) had BNP levels greater than or equal to 20 pg/ml ( p  = 0.019). There were no differences in BNP levels of SLE patients with and without diastolic dysfunction (median 17.8 range [5–117] pg/ml vs. median 18.5 range [5–211] pg/mL; p  = NS). BNP levels were positively correlated with left atrium diameter ( r 2  = 0.39, p  = 0.001). BNP levels did not correlate with erythrocyte sedimentation rate/C-reactive protein levels, SLEDAI scores, total steroid dosage used, or other echocardigraphic parameters. BNP levels were increased in female SLE patients without cardiac symptoms as compared to healthy controls. Although none of the SLE patients in our study had clinical signs of ischemic heart disease, increased levels of BNP in SLE patients might be a reflection of a ischemic myocardial tissue.
subject
0B-type natriuretic peptide (BNP)
1Cardiovascular diseases
2Diastolic dysfunction
3Novel cardiovascular risk factors
4Systemic lupus erythematosus (SLE)
general
010.1007/s10067-007-0575-4
1English
2Springer Science & Business Media B.V.
3SpringerLink
sourceidspringer_jour
recordidspringer_jour10.1007/s10067-007-0575-4
issn
01434-9949
114349949
20770-3198
307703198
rsrctypearticle
creationdate2007
addtitle
0Clinical Rheumatology
1Journal of the International League of Associations for Rheumatology
2Clin Rheumatol
searchscopespringer_journals_complete
scopespringer_journals_complete
lsr30VSR-Enriched:[galeid, pages, pqid]
sort
titleB-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
authorKaradag, Omer ; Calguneri, Meral ; Yavuz, Bunyamin ; Atalar, Enver ; Akdogan, Ali ; Kalyoncu, Umut ; Kiraz, Sedat ; Aksoyek, Serdar ; Ozmen, Ferhan ; Ertenli, A.
creationdate20071000
facets
frbrgroupid5826072599585767024
frbrtype5
languageeng
creationdate2007
topic
0B-Type Natriuretic Peptide (Bnp)
1Cardiovascular Diseases
2Diastolic Dysfunction
3Novel Cardiovascular Risk Factors
4Systemic Lupus Erythematosus (Sle)
collectionSpringerLink
prefilterarticles
rsrctypearticles
creatorcontrib
0Karadag, Omer
1Calguneri, Meral
2Yavuz, Bunyamin
3Atalar, Enver
4Akdogan, Ali
5Kalyoncu, Umut
6Kiraz, Sedat
7Aksoyek, Serdar
8Ozmen, Ferhan
9Ertenli, A.
jtitleClinical Rheumatology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Karadag
1Calguneri
2Yavuz
3Atalar
4Akdogan
5Kalyoncu
6Kiraz
7Aksoyek
8Ozmen
9Ertenli
aufirst
0Omer
1Meral
2Bunyamin
3Enver
4Ali
5Umut
6Sedat
7Serdar
8Ferhan
9A.
10Ihsan
au
0Karadag, Omer
1Calguneri, Meral
2Yavuz, Bunyamin
3Atalar, Enver
4Akdogan, Ali
5Kalyoncu, Umut
6Kiraz, Sedat
7Aksoyek, Serdar
8Ozmen, Ferhan
9Ertenli, A.
atitleB-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?
jtitleClinical Rheumatology
stitleClin Rheumatol
addtitleJournal of the International League of Associations for Rheumatology
risdate200710
volume26
issue10
spage1701
epage1704
issn0770-3198
eissn1434-9949
genrearticle
ristypeJOUR
abstractCardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE) especially during the late phase of the disease. This study was conducted to evaluate B-type natriuretic peptide (BNP) levels in female SLE patients without cardiac symptoms and to investigate whether BNP levels correlated with echocardiographic findings. We studied 59 women with SLE and 33 healthy women. SLE patients with history of cardiac disease, diabetes mellitus, hypertension, and other inflammatory diseases were excluded from the study. All subjects had a complete history and physical examination. Overall disease activity assessment in SLE patients at the time of the study were derived by calculation of SLE disease activity index (SLEDAI). BNP levels were determined, and transthoracic echocardiography were performed in all subjects. There was no difference between SLE patients and controls in terms of age, blood pressure, smoking status, plasma glucose, creatinine levels, and lipid profiles. Nine patients had SLEDAI score greater than 5. All subjects had an EF greater than 55%. Diastolic dysfunction was more frequent in lupus patients than in controls (15 [25.4%] vs. 2 [6%]; p  = 0.022). BNP levels of SLE patients were significantly higher than controls (median 17.9 range [5–211] pg/ml vs. median 14.7 range [5–39.7] pg/ml; p  = 0.033). Twenty-seven of the SLE patients (46%) and seven of the controls (21%) had BNP levels greater than or equal to 20 pg/ml ( p  = 0.019). There were no differences in BNP levels of SLE patients with and without diastolic dysfunction (median 17.8 range [5–117] pg/ml vs. median 18.5 range [5–211] pg/mL; p  = NS). BNP levels were positively correlated with left atrium diameter ( r 2  = 0.39, p  = 0.001). BNP levels did not correlate with erythrocyte sedimentation rate/C-reactive protein levels, SLEDAI scores, total steroid dosage used, or other echocardigraphic parameters. BNP levels were increased in female SLE patients without cardiac symptoms as compared to healthy controls. Although none of the SLE patients in our study had clinical signs of ischemic heart disease, increased levels of BNP in SLE patients might be a reflection of a ischemic myocardial tissue.
copLondon
pubSpringer-Verlag
doi10.1007/s10067-007-0575-4
pages1701-1704
date2007-10